StockNews.com Initiates Coverage on Cutera (NASDAQ:CUTR)

Stock analysts at StockNews.com initiated coverage on shares of Cutera (NASDAQ:CUTR) in a research note issued on Tuesday. The firm set a “sell” rating on the medical device company’s stock.

Cutera Trading Down 63.9 %

Cutera stock opened at $0.04 on Tuesday. The firm’s 50 day simple moving average is $0.35 and its 200 day simple moving average is $0.48. The firm has a market capitalization of $787,254.00, a PE ratio of -0.01 and a beta of 1.36. Cutera has a 1-year low of $0.09 and a 1-year high of $3.00.

Hedge Funds Weigh In On Cutera

A hedge fund recently bought a new stake in Cutera stock. Sculptor Capital LP purchased a new position in Cutera, Inc. (NASDAQ:CUTR) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 166,000 shares of the medical device company’s stock, valued at approximately $59,000. Sculptor Capital LP owned about 0.82% of Cutera at the end of the most recent reporting period. 90.70% of the stock is currently owned by institutional investors and hedge funds.

About Cutera

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.